KBC Group
GH icon

KBC Group’s Guardant Health GH Stock Holding History

KBC Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
8,920
+1,383
+18% +$150K ﹤0.01% 715
2026
Q1 		$696K Buy
7,537
+4,403
+140% +$442K ﹤0.01% 757
2025
Q4 		$320K Hold
3,134
– – ﹤0.01% 782
2025
Q3 		$196K Hold
3,134
– – ﹤0.01% 911
2025
Q2 		$163K Sell
3,134
-2,503
-44% -$112K ﹤0.01% 947
2025
Q1 		$240K Sell
5,637
-21
-0.4% -$906 ﹤0.01% 970
2024
Q4 		$173K Buy
5,658
+2,200
+64% +$61.9K ﹤0.01% 1211
2024
Q3 		$79K Hold
3,458
– – ﹤0.01% 1443
2024
Q2 		$100K Hold
3,458
– – ﹤0.01% 1160
2024
Q1 		$71K Buy
3,458
+1,080
+45% +$23.2K ﹤0.01% 1323
2023
Q4 		$64K Hold
2,378
– – ﹤0.01% 1349
2023
Q3 		$70K Buy
+2,378
New +$83.6K ﹤0.01% 1188

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

KBC Group's GH Position: Q2 2026 in Review

KBC Group increased its Guardant Health (GH) stake by 18% in Q2 2026, buying an estimated $150K and bringing the position to 8,920 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #715.

KBC Group first reported a position in GH in Q3 2023 and has held it in 12 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • KBC Group held 8,920 shares of Guardant Health worth $1.34M as of Q2 2026.
  • KBC Group bought 1,383 Guardant Health shares in Q2 2026, an estimated $150K.
  • Guardant Health made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #715 holding.
  • KBC Group first reported a position in Guardant Health in Q3 2023 and has held it in 12 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.